Comparative Study of Three Common Bile Duct Closure Techniques

May 7, 2021 updated by: Mohammed Ahmed Omar, South Valley University

Comparative Study of Three Common Bile Duct Closure Techniques After Choledocholithotomy: Safety and Efficacy

This study evaluates the efficacy and safety of three different methods of CBD repair after common bile duct exploration and provides more evidence for selecting the optimal duct closure after choledocholithotomy.

Study Overview

Detailed Description

At present, the commonest available options for CBD closure include repair over T-tube drain, primary closure, and repair after antegrade biliary stenting. All three methods present specific technical performance features, require different postoperative management protocols, and are charged with specific morbidity related to the procedure and therefore should not be considered the same procedure in the context of CBDE.

Repair over T-tube is the traditional surgical technique. It has many advantages as post-operative distal CBD decompression, trans-tubal cholangiography, and availability of retained CBD stones extraction. However, it has several potential complications up to 10% of patients. The most frequent complications are bile leakage, tract infection, T-tube dislodgement, electrolyte and nutritional disturbances, cholangitis, or acute renal failure from dehydration due to inadequate water ingestion. It also causes discomfort and persistent pain to the patient along with increased hospital admission and thus the economic burden to the country. Primary closure of CBD has been described in the literature to overcome these adverse consequences of the T-tube. However, it has many potential complications as a potential bile leak and CBD stricture, which may occur due to papillary edema and insufficient bile duct expansion. There are conflicting results regarding significant differences in the morbidity and mortality between primary closure and T-tube drainage. There is no conclusive evidence displaying whether primary closure is better or worse than T-tube drainage after CBD exploration.

Using a biliary stent in primary closure is an effective method to decrease the two complications, which can reduce biliary pressure without bile loss. Although there are some available drainage options after CBDE, a consensus on the optimal drainage is yet to be reached.

Study Type

Interventional

Enrollment (Actual)

211

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Qena
      • Sohag, Qena, Egypt, 83523
        • Mohammed Ahmed Omar

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion criteria

  • CBD stones
  • age from 20 to 80,
  • CBD > 0.8 cm and < 2.5 cm,
  • American Society of Anesthesiologists (ASA) grade I, II or III,
  • agreement to randomization and complete the study requirement. Exclusion criteria
  • acute suppurative cholangitis,
  • acute biliary pancreatitis,
  • biliary malignancy,
  • biliary malformation,
  • distal CBD stenosis and or obstruction,
  • trans-cystic stone extraction,
  • explorations followed by choledochojejunostomy and choledochoduodenostomy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: T tube drainage
Closure of common bile duct after choledocholithotomy over T tube
Primary closure of common bile duct
Closure of common bile duct over antegrade plastic biliary stent
Experimental: Primary closure
Primary closure of the common bile duct after choledocholithotomy
Closure of common bile duct over antegrade plastic biliary stent
closure of common bile duct over T tube
Experimental: Antegrade stenting
Closure of common bile duct over antegrade biliary plastic stent
Primary closure of common bile duct
closure of common bile duct over T tube

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative bile leak
Time Frame: 3rd to 7th postoperative day
The discharge of fluid via intra-abdominal drain or intra-abdominal fluid with bilirubin concentration at least 3 times the serum bilirubin concentration measured at the same time on or after the 3rd postoperative day, or as the need for radiologic or surgical intervention because of biliary collections.
3rd to 7th postoperative day
Post operative biliary stricture
Time Frame: 6 month
The segmental shrunken of CBD diameter and proximal dilatation by MRCP.
6 month
Recurrent biliary stones
Time Frame: 6 month
Common bile duct stone after 6 months of the procedure
6 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual analogue score
Time Frame: 3 days
the severity of postoperative pain. from 0 (no pain) to 10 (maximum pain)
3 days
The number of patients need postoperative opioid
Time Frame: 3 days
The patients need of postoperative opioid (pethidine Hcl 50 mg)
3 days
Postoperative bilirubin level
Time Frame: 7 days
the rate of decreased bilirubin postoperatively
7 days
Hospital stays
Time Frame: 10 days
the number of days in hospital from the day of operation to the day of discharge
10 days
Drain-carried time
Time Frame: 20 days
the number of days before drain removal
20 days
Total cost of treatment
Time Frame: Through study completion, average 6 month
The cost of intervention and management of postoperative complications
Through study completion, average 6 month
Return to normal activity
Time Frame: 30 days
the number of days required for the patient to return to normal activity
30 days
Type of re-intervention
Time Frame: 6 month
the number of intervention required for each patient totally
6 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Mohammed A. Omar, Ass. Prof., South Valley University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2017

Primary Completion (Actual)

January 1, 2020

Study Completion (Actual)

April 30, 2021

Study Registration Dates

First Submitted

February 7, 2020

First Submitted That Met QC Criteria

February 7, 2020

First Posted (Actual)

February 11, 2020

Study Record Updates

Last Update Posted (Actual)

May 11, 2021

Last Update Submitted That Met QC Criteria

May 7, 2021

Last Verified

May 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • SVU 300

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Common Bile Duct Closure

Clinical Trials on Primary closure

Subscribe